Filter by:
Muscular Dystrophy
October 2024
World Muscle Society 2024
Post-Exercise Biomarkers of Muscle Injury are Reduced by Sevasemten, a Fast Myosin Inhibitor, in Adults with Becker Muscular Dystrophy
Muscular Dystrophy
October 2024
World Muscle Society 2024
Protein Biomarkers of Muscle Injury Exhibit Differential Reduction with Subject Age in Adults with Becker Muscular Dystrophy
Muscular Dystrophy
October 2024
World Muscle Society 2024
Clinical Trial Readiness in a Rare and Underserved Disease: Learnings from Community Engagement and the Lived Experience in Becker Muscular Dystrophy (Becker)
Muscular Dystrophy
October 2024
World Muscle Society 2024
Sevasemten, a Fast Myosin Inhibitor, in Adults with Becker Muscular Dystrophy Results in Reduced Muscle Damage Biomarkers and Functional Stabilization
Muscular Dystrophy
October 2024
World Muscle Society 2024
Comparison of short- and long-term proteomic response to the fast skeletal myosin inhibitor, sevasemten (EDG-5506), in Becker muscular dystrophy (BMD)
Muscular Dystrophy
October 2024
World Muscle Society 2024
